Where the stock stands
Aster DM Quality Care Ltd. trades as ASTERDM in the Healthcare sector. Beyond the name and that sector label, this pack says nothing about what the company does.
On 7 August 2026 the stock closed at 869.7, up 2.99% from the previous close of 844.45, on a day the Nifty slipped 0.27%. That close sits 0.65% below the 52-week high of 875.35 and 67.54% above the 52-week low of 519.1 -- the upper end of its one-year range, not the bottom. The trailing returns agree: up 5.78% over a week, 7.74% over a month, 19.07% over three months and 48.42% over a year.
On valuation, the pack puts the price-to-earnings ratio at 115.65 against earnings per share of 7.52, price-to-book at 9.79 and the dividend yield at 0.46%. A headline from NDTV Profit dated two days before this snapshot reports that first-quarter profit fell 81%, weighed down by a one-time loss, with revenue crossing Rs 1,300 crore. A reported profit fall of that size alongside a stock a fraction below its 52-week high is a real tension in this pack, and nothing here resolves it.
What the smart-money flow shows
This is normally the richest section. Here it is the emptiest, which is itself the finding. The pack carries no futures-and-options positioning field at all -- not an empty record showing no activity, but a key that is simply absent. So nothing can be said about open interest, or about whether fresh futures positions were opened as the price rose (a "long buildup") or as it fell. A directional reading of that absence would be invented.
The same holds for the other trails: no bulk-deal or block-deal entries, no named institutional counterparties, no record of institutional accumulation or distribution streaks, and no insider or promoter-transaction filings. None of those channels reports that nothing happened; they are missing from the evidence, and the distinction matters.
What the pack does carry from the exchange is a list of NSE filings, which repeat across consecutive dates. Three entries dated 5, 6 and 7 August all describe one disclosure, about the acquisition of equity shares of United CIIGMA Institute of Medical Sciences, described as a subsidiary. Three more, dated 13, 14 and 15 July, all describe one allotment of shares to shareholders of a transferor company (QCIL) under a scheme of amalgamation. That is two events re-listed, not six; adding the rows up would overstate the activity threefold. The July filings also carry the name Aster DM Healthcare Limited while the pack names the company Aster DM Quality Care Ltd.; the difference is unexplained.
The technical picture
The 14-day relative strength index reads 71.7. Readings in the seventies are conventionally called overbought -- a measure of how persistently recent gains have outweighed declines, not a forecast. Relative volume is 1.66, meaning turnover ran at 1.66 times its usual level.
On trend, the close is above both the 50-day and the 200-day moving average, but neither a golden cross nor a death cross -- those averages crossing upward or downward -- is flagged in the window the pack covers. The standing comes from price above both lines, not a fresh crossover.
Catalysts and what to watch
The only dated catalysts are those two exchange disclosures, both tagged acquisition or M&A.
The news list is thinner than its length suggests. Four of the six items are routine live-price tracker pages from CNBC TV18, ICICI Direct and The Economic Times; two more are split-history and dividend-history reference pages from India Infoline -- standing web pages, not events. Only the NDTV Profit results headline reports something that happened.
What this pack establishes: a stock near the upper end of its one-year range, above both long moving averages, on a high price-to-earnings multiple, with two repeated M&A-related filings and a reported sharp fall in quarterly profit. What it does not establish: any derivatives, institutional or insider flow, because those fields are absent rather than zero. Nothing here identifies a single driver for the move.